Financials & Filings Show all 2022 Third Quarter Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update Form 10-Q Annual Reports Title View Add Files 2020 Form 10-K 734 KB Add Files 2020 Form 10-K 734 KB Add Files 2019 Form 10-K 737.2 KB Add Files 2019 Form 10-K 737.2 KB Proxy Statements There are no SEC filings available. Form 10-K Filing date View Mar 31, 2003 View HTML 0000927016-03-001537.pdf 0000927016-03-001537.xls Mar 30, 2004 View HTML 0001193125-04-053930.pdf 0001193125-04-053930.xls Form 10-Q Filing date View May 17, 2004 View HTML 0001193125-04-089942.pdf 0001193125-04-089942.xls Aug 16, 2004 View HTML 0001193125-04-141624.pdf 0001193125-04-141624.xls